# Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

> **NCT01351025** · PHASE2 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 98 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** atorvastatin
- **DRUG:** atorvastatin
- **DRUG:** placebo for atorvastin

## Key facts

- **NCT ID:** NCT01351025
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-14
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01351025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01351025, "Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01351025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*